Journal of the National Cancer Institute Advance Access originally published online on July 8, 2008
JNCI Journal of the National Cancer Institute 2008 100(14):980-982; doi:10.1093/jnci/djn249
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© Oxford University Press 2008.
NEWS |
Ontario Institute Offers New Model of Cancer Research
| The first 150 words of the full text of this article appear below. |
Ten next-generation DNA sequencers fill two rooms in the gleaming MaRS Centre, a modern laboratory and office building in downtown Toronto. These machines symbolize today's genetics. They belong to the Ontario Institute of Cancer Research (OICR), a 3-year-old nonprofit corporation that will soon use the machines to sequence the genomes of hundreds of human pancreatic cancers to identify cancer-associated gene alterations.
| |||||||||||
Five floors below, near the MaRS Centre reception area, sits a plain wooden desk. For Canadians, the symbolism here is equally potent: It's the desk of Frederick Banting, M.D., the University of Toronto surgeon who, with student Charles Best, discovered insulin in 1921. Within 2 years, insulin was fully available commercially and was transforming the lives of diabetic children and adults. The
Spreading the Wealth
Targeting Stem Cells
Freeing the Imaging Imagination
Deconstructing Pancreatic Cancer
Ontario and the World